Association of tryptophan hydroxylase 2 gene polymorphisms with major depression disorder and antidepressant treatment response

Journal of Shanghai Jiaotong University (Medical Science)

Volumn 30, Issue 6, 2010, Pages 612-615

  Cao, Lan ^a   Fang, Yi Ru ^a   Yu, Shun Ying ^a   Hu, Ying Yan ^a   Hong, Wu ^a   Zhang, Chen ^a   Yi, Zheng Hui ^a   Yuan, Cheng Mei ^a   Chen, Jun ^a   Wu, Zhi Guo ^a   Li, Ze Zhi ^a   Huang, Jia ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Gene; Major depression disorder; Treatment response; Tryptophan hydroxylase 2

Indexed keywords

ANTIDEPRESSANT AGENT; TRYPTOPHAN HYDROXYLASE 2;

ARTICLE; CHINESE; CONTROLLED STUDY; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MENTAL PATIENT; PROMOTER REGION; PSYCHOPHARMACOTHERAPY; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

EID: 77955972718     PISSN: 16748115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Spiessl H, Hubner-Liebermann B, Hajak G. Depression, a widespread disease. Epidemiology, care situation, diagnosis, therapy and prevention[J]. Dtsch Med Wochenschr, 2006, 131(1-2): 35-40.
2. Terwilliger JD, Weiss KM. Linkage disequilibrium mapping of complex disease: fantasy or reality[J]? Curr Opin Biotechnol, 1998, 9(6): 578-594.
3. Cardon LR, Bell JI. Association study designs for complex diseases[J]. Nat Rev Genet, 2001, 2(2): 91-99.
4. Ardlie KG, Kruglyak L, Seielstad M. Patterns of linkage disequilibrium in the human genome[J]. Nat Rev Genet, 2002, 3(4): 299-309.
5. Coppen A, Shaw DM, Herzberg B, et al. Tryptophan in treatment of depression[J]. Lancet, 1967, 2(7527): 1178-1180.
6. Anguelova M, Benkelfat C, Turecki G. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: Affective disorders[J]. Mol Psychiatry, 2003, 8(6): 574-591. (Pubitemid 36898017)
7. Zill P, Baghai TC, Zwanzger P, et al. SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression[J]. Mol Psychiatry, 2004, 9(11): 1030-1036.
8. Van Den Bogaert A, Sleegers K, De Zutter S, et al. Association of brain-specific tryptophan hydroxylase, TPH2, with unipolar and bipolar disorder in a Northern Swedish, isolated population[J]. Arch Gen Psychiatry, 2006, 63(10): 1103-1110.
9. Tzvetkov MV, Brockmöller J, Roots I, et al. Common genetic variations in human brain-specific tryptophan hydroxylase-2 and response to antidepressant treatment[J]. Pharmacogenet Genomics, 2008, 18(6): 495-506.
10. Tsai SJ, Hong CJ, Liou YJ, et al. Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2009, 33(4): 637-641.
11. Gizatullin R, Zaboli G, Jönsson EG, et al. The tryptophan hydroxylase (TPH) 2 gene unlike TPH-1 exhibits no association with stress-induced depression[J]. J Affect Disord, 2008, 107(1-3): 175-179.
12. Mann JJ, Currier D, Murphy L, et al. No association between a TPH2 promoter polymorphism and mood disorders or monoamine turnover[J]. J Affect Disorder, 2008, 106(1-2): 117-121.
13. Zhang YQ, Yuan GZ, Li GL, et al. A case-control study on the risk factors for attempted suicide in patients with major depression[J]. Zhonghua Liu Xing Bing Xue Za Zhi, 2007, 28(2): 131-135.